{
    "2020-11-16": [
        [
            {
                "time": "2023-10-25",
                "original_text": "【爱美客|事件点评】利拉鲁肽注射液获临床批件，减肥（重）领域布局增量可期【安信医药马帅团队】",
                "features": {
                    "keywords": [
                        "利拉鲁肽",
                        "临床批件",
                        "减肥",
                        "增量"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-26",
                "original_text": "“暴利”医美股：利润率堪比茅台，美容像打游戏一样上瘾",
                "features": {
                    "keywords": [
                        "暴利",
                        "医美",
                        "利润率",
                        "茅台"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-27",
                "original_text": "上市30天暴涨450%！爱美客火了，毛利比茅台还高",
                "features": {
                    "keywords": [
                        "上市",
                        "暴涨",
                        "爱美客",
                        "毛利",
                        "茅台"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-28",
                "original_text": "“医美之王”爱美客暴利背后瓶颈未破！",
                "features": {
                    "keywords": [
                        "医美之王",
                        "爱美客",
                        "暴利",
                        "瓶颈"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-29",
                "original_text": "溢价300倍，成本33元最高售价1万！堪比茅台的暴利行业涨嗨了，概念股全名单请收藏，一则公告引爆冷门股",
                "features": {
                    "keywords": [
                        "溢价",
                        "暴利",
                        "茅台",
                        "公告",
                        "冷门股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-30",
                "original_text": "[10月社零同比+4.3%，餐饮消费增速年内首次转正] 开源零售黄泽鹏团队",
                "features": {
                    "keywords": [
                        "社零",
                        "餐饮消费",
                        "增速",
                        "转正"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-31",
                "original_text": "爱美客（300896）事件点评：利拉鲁肽临床试验获批，减肥减重产品取得积极进展【东吴医药&社服零售】",
                "features": {
                    "keywords": [
                        "爱美客",
                        "利拉鲁肽",
                        "临床试验",
                        "减肥",
                        "进展"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}